{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:33Z","timestamp":1793995593604,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1053\/j.gastro.2008.08.057","type":"journal-article","created":{"date-parts":[[2008,9,14]],"date-time":"2008-09-14T04:30:02Z","timestamp":1221366602000},"page":"1953-1960","source":"Crossref","is-referenced-by-count":294,"title":["A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis"],"prefix":"10.1053","volume":"135","author":[{"given":"Nicholas C.","family":"Boetticher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Peine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Aqel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Boardman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2008.08.057_bib1","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","article-title":"Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology","volume":"93","author":"McCullough","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2008.08.057_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","article-title":"Alcoholic liver disease: new insights in pathogenesis lead to new treatments","volume":"32","author":"Lieber","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4065\/76.10.1021","article-title":"Pathogenesis, diagnosis, and treatment of alcoholic liver disease","volume":"76","author":"Menon","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2008.08.057_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0016-5085(81)90250-X","article-title":"A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients","volume":"80","author":"Baker","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis","volume":"82","author":"Halle","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90973-5","article-title":"Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis","volume":"99","author":"Akriviadis","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(92)91156-X","article-title":"Nutritional therapy for alcoholic hepatitis","volume":"103","author":"Morgan","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2008.08.057_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2008.08.057_bib10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib11","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1053\/gast.2000.20826","article-title":"Pentoxifylline and alcoholic hepatitis","volume":"119","author":"Morgan","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo-controlled, double-blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-\u03b1 monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","article-title":"Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival","volume":"128","author":"Morgan","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib15","first-page":"307","article-title":"Cytokines\u2014central factors in alcoholic liver disease","volume":"27","author":"Neuman","year":"2003","journal-title":"Alcohol Res Health"},{"key":"10.1053\/j.gastro.2008.08.057_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2004-832939","article-title":"Cellular signaling mechanisms in alcohol-induced liver damage","volume":"24","author":"Hoek","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2008.08.057_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1572-0241.2005.41509.x","article-title":"Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease","volume":"100","author":"Latvala","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2008.08.057_bib18","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1097\/01.alc.0000189276.34230.f5","article-title":"Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease","volume":"29","author":"McClain","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1053\/j.gastro.2008.08.057_bib19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2008.08.057_bib20","first-page":"A441","article-title":"Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis","volume":"34","author":"Jalan","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2008.08.057_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2008.08.057_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/rheumatology\/41.2.228","article-title":"Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis","volume":"41","author":"ten Cate","year":"2002","journal-title":"Rheumatology"},{"key":"10.1053\/j.gastro.2008.08.057_bib24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor \u03b1","volume":"346","author":"Gorman","year":"2002","journal-title":"N Eng J Med"},{"key":"10.1053\/j.gastro.2008.08.057_bib25","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood.V99.6.2252","article-title":"Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study","volume":"99","author":"Steensma","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2008.08.057_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/art1.10243","article-title":"Experience with etanercept in an academic medical center: are infection rates increased?","volume":"47","author":"Phillips","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2008.08.057_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"Safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2008.08.057_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2008.08.057_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2001","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2008.08.057_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0168-8278(04)00064-9","article-title":"Model for End-Stage Liver Disease score predicts mortality across a broad spectrum of liver disease","volume":"40","author":"Said","year":"2004","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2008.08.057_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib35","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2008.08.057_bib36","first-page":"1220","article-title":"Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models","volume":"146","author":"Leist","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2008.08.057_bib37","first-page":"503","article-title":"Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease","volume":"33","author":"Schafer","year":"1995","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1053\/j.gastro.2008.08.057_bib38","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1164\/ajrccm.157.5.9709067","article-title":"Cholestatic liver injury increases circulating TNF-\u03b1 and IL-6 and mortality after Escherichia coli endotoxemia","volume":"157","author":"Lechner","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.gastro.2008.08.057_bib39","first-page":"1577","article-title":"Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor","volume":"152","author":"Yamada","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/j.gastro.2008.08.057_bib40","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","article-title":"Essential role of tumor necrosis factor \u03b1 in alcohol-induced liver injury in mice","volume":"117","author":"Yin","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2008.08.057_bib41","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4049\/jimmunol.164.2.872","article-title":"TNF-\u03b1 regulates TGF \u03b1 expression in regenerating murine liver and isolated hepatocytes","volume":"164","author":"Gallucci","year":"2000","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2008.08.057_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q","article-title":"TNF-\u03b1 gene polymorphism: clinical and biological implications","volume":"50","author":"Hajeer","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1053\/j.gastro.2008.08.057_bib43","first-page":"G579","article-title":"Antibodies to tumor necrosis factor-\u03b1 inhibit liver regeneration after partial hepatectomy","volume":"263","author":"Akerman","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1053\/j.gastro.2008.08.057_bib44","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","article-title":"TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection","volume":"168","author":"Roach","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2008.08.057_bib45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508508016697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508508016697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T04:05:36Z","timestamp":1588910736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508508016697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0016508508016697"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2008.08.057","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}